Michael A. Metzger - Sep 20, 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
President and COO, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Sep 20, 2021
Transactions value $
-$439,607
Form type
4
Date filed
9/22/2021, 04:50 PM
Previous filing
Sep 15, 2021
Next filing
Sep 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $226K +31.5K +178.12% $7.20 49.1K Sep 20, 2021 Direct
transaction SNDX Common Stock Sale -$605K -31.5K -64.04% $19.24 17.7K Sep 20, 2021 Direct F1, F2
transaction SNDX Common Stock Options Exercise $34.6K +4.81K +27.23% $7.20 22.5K Sep 21, 2021 Direct
transaction SNDX Common Stock Sale -$92.1K -4.81K -21.4% $19.16 17.7K Sep 21, 2021 Direct F1, F3
transaction SNDX Common Stock Options Exercise $2.16K +300 +1.7% $7.20 18K Sep 22, 2021 Direct
transaction SNDX Common Stock Sale -$5.71K -300 -1.67% $19.02 17.7K Sep 22, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -31.5K -100% $0.00* 0 Sep 20, 2021 Common Stock 31.5K $7.20 Direct F5
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -4.81K -100% $0.00* 0 Sep 21, 2021 Common Stock 4.81K $7.20 Direct F5
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -300 -100% $0.00* 0 Sep 22, 2021 Common Stock 300 $7.20 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
F2 The sale price ranged from $19.00 to $19.92
F3 The sale prices ranged from $19.02 to $19.31
F4 The sale prices ranged from $19.00 to $19.06
F5 This option is fully vested.